Research conducted by scientists from the UC Santa Cruz Genomics Institute have led to the development of new companies. As a result, these organizations specialize in genomic processing and analysis. Here is a sampling of our most recent spin-offs:
In vitro binding approach simplifying genomic analysis with the help of high quality genomic information and data processing.
The UC Santa Cruz Genomics Institute has contributed intellectual property (IP core) to Oxford Nanopore Technologies (UK).